IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist

Affiliations

¹ 1] Institute of Pharmacology, University of Bern, CH-3010 Bern, Switzerland. [2].
² 1] Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Aviv University, Tel Aviv 5262225, Israel. Yehuda Shoenfeld is also at the Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel Aviv University, Tel Aviv 5262225, Israel. [2].
³ 1] Department of Medicine, University of Toronto, and Centre for Innovation, Canadian Blood Services, Toronto, Ontario M5G 2M1, Canada. [2].
⁴ 1] Department of Immunology, Stefan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Sofia 1113, Bulgaria. [2].
⁵ 1] Research and Development, CSL Behring AG, CH-3000 Bern, Switzerland. [2].
⁶ 1] Institut National de la Santé et de la Recherche Médicale, Paris, France; Université Pierre et Marie Curie, Paris 6, Centre de Recherche des Cordeliers, 75006 Paris, France. [2].

Comment

Stephan von Gunten et al. Nat Rev Immunol. 2014 May.

. 2014 May;14(5):349.

doi: 10.1038/nri3401-c1.

¹ 1] Institute of Pharmacology, University of Bern, CH-3010 Bern, Switzerland. [2].
² 1] Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Aviv University, Tel Aviv 5262225, Israel. Yehuda Shoenfeld is also at the Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel Aviv University, Tel Aviv 5262225, Israel. [2].
³ 1] Department of Medicine, University of Toronto, and Centre for Innovation, Canadian Blood Services, Toronto, Ontario M5G 2M1, Canada. [2].
⁴ 1] Department of Immunology, Stefan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Sofia 1113, Bulgaria. [2].
⁵ 1] Research and Development, CSL Behring AG, CH-3000 Bern, Switzerland. [2].
⁶ 1] Institut National de la Santé et de la Recherche Médicale, Paris, France; Université Pierre et Marie Curie, Paris 6, Centre de Recherche des Cordeliers, 75006 Paris, France. [2].

No abstract available

Comment in

Reply to - IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist.
Schwab I, Lux A, Nimmerjahn F. Schwab I, et al. Nat Rev Immunol. 2014 May;14(5):349. doi: 10.1038/nri3401-c2. Nat Rev Immunol. 2014. PMID: 24762828 No abstract available.

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Schwab I, Nimmerjahn F. Schwab I, et al. Nat Rev Immunol. 2013 Mar;13(3):176-89. doi: 10.1038/nri3401. Epub 2013 Feb 15. Nat Rev Immunol. 2013. PMID: 23411799 Review.